ClassID:

95112

C07D317/32 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Sub-classes:
Recent Application in this class:
#1
20250152518
2025-05-15

PEG LIPIDS AND USES THEREOF

#2
20250122194
2025-04-17

NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS

#3
20240246925
2024-07-25

MANUFACTURING METHOD OF 1,4-DIOXANE DERIVATIVE, 1,4-DIOXANE DERIVATIVE, COMPOSITION CONTAINING 1,4-DIOXANE DERIVATIVE, AND MANUFACTURING METHOD OF (1,3-DIOXOLANE)-2- CARBOXYLIC ACID DERIVATIVE, (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE, AND COMPOSITION CONTAINING (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE

#4
20230113085
2023-04-13

Small molecule inhibitors of TEAD transcription factors

#5
20220047518
2022-02-17

PEG lipids and uses thereof

#6
20200087290
2020-03-19

Method for producing glyceric acid ester

#7
20190330173
2019-10-31

Method for manufacturing 1,3-dioxane-5-one

#8
20190322654
2019-10-24

Method for producing glyceric acid ester

#9
20190100548
2019-04-04

Anthracycline Derivatives For Treating Tumor Diseases

#10
20170303581
2017-10-26

Aerosol-generating system comprising a novel delivery enhancing compound source

#11
20170226317
2017-08-10

Polarizing plate protective film, polarizing plate, and display device

#12
20160166545
2016-06-16

Combinations comprising biphenyl derivatives for use in the treatment of HCV

#13
20150252069
2015-09-10

Anthracycline derivatives for treating tumor diseases

#14
20150119573
2015-04-30

Method for synthesizing sapropterin dihydrochloride

#15
20150105555
2015-04-16

Method for synthesizing sapropterin dihydrochloride

#16
20140155635
2014-06-05

RESORCYLIC ACID LACTONE COMPOUNDS

#17
20120130092
2012-05-24

Nitro group-containing ether compound and method for producing same

#18
20110319586
2011-12-29

Ketal compounds from polyols and oxocarboxylates

#19
20100267946
2010-10-21

Prodrugs of GABA analogs, compositions and uses thereof

#20
20100022767
2010-01-28

DEVELOPMENT OF A SYNTHESIS OF SYRINGOLIN A AND B AND DERIVATIVES THEREOF

#21
20090318650
2009-12-24

Fluorine-containing polymer and method of producing fluorine-containing polymer

#22
20090163576
2009-06-25

Compounds for the treatment of metabolic disorders

#23
20090099253
2009-04-16

Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use

#24
20090076302
2009-03-19

Process for preparing α-keto acids and derivatives thereof

#25
20080306231
2008-12-11

Novel perfluoroalkyl vinyl ether compound, process for preparing copolymer by using the compound, and optical plastic materials comprising copolymer prepared by the process

#26
20080171767
2008-07-17

Acetamide compounds as fungicides

#27
20080167371
2008-07-10

Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof

#28
20070142230
2007-06-21

Benzoyl-substituted phenylalanineamides

#29
20070037943
2007-02-15

Process for preparing perfluoroalkyl vinyl ether copolymer and copolymer

#30
20070010453
2007-01-11

Prodrugs of GABA analogs, compositions and uses thereof

#31
20060134763
2006-06-22

Stereoselective process for the production of dioxolane nucleoside analogues

#32
20050192286
2005-09-01

Ligands of melanocortin receptors and compositions and methods related thereto

#33
20050148800
2005-07-07

Perfluoroalkyl vinyl ether compound, process for preparing copolymer by using the compound, and optical plastic materials comprising copolymer prepared by the process

#34
20050014833
2005-01-20

Cyclic compound and PPAR agonist